On January 7, 2019, PEAR Therapeutics and Sandoz announced the commercial launch of reSET-OT, a mobile medical digital therapeutic application to treat opioid use disorder (OUD). reSET-O, which is available immediately, was developed by PEAR Therapeutics and is being commercialized by Sandoz.

The reSET-O application is a 12-week prescription digital therapeutic (PDT) that provides adjunctive cognitive behavioral therapy (CBT) for adults with OUD enrolled in outpatient treatment and being treated with transmucosal buprenorphine. The application also includes a contingency management program, which is a behavior modification intervention. Use is limited to persons with a valid prescription . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.